Biocryst Pharmaceuticals (BCRX) Enterprise Value (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Enterprise Value of $2.2 billion in Q2 2026, up 35.7% from $1.62 billion a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Enterprise Value (2010 - 2026) Analysis & Trends
On a TTM basis, Biocryst Pharmaceuticals' Enterprise Value came in at $1.47 billion as of Jun 30, 2026, up 118.5% year-over-year; for FY2025, it came in at $1.39 billion, up 11.2% from FY2024.
- Annual Enterprise Value has a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- Across earlier years, Enterprise Value came in at $1.25 billion in FY2024 (+47.9%), $843.58 million in FY2023 (-51.3%), $1.73 billion in FY2022 (-15.3%) and $2.05 billion in FY2021 (+101.1%).
- The Q2 2026 figure is the highest quarterly Enterprise Value since Q1 2022.
- On a year-over-year basis, Enterprise Value has increased for nine consecutive quarters, with growth averaging 43.6% over the last eight quarters.
- Peak year-over-year performance for Enterprise Value in the last five years was growth of 101.1% in Q4 2021, against a decline of 54.3% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.18 billion (Q1 2026), $1.39 billion (Q4 2025) and $1.38 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.20 Bn |
| Mar 31, 2026 | 2.18 Bn |
| Dec 31, 2025 | 1.39 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 1.62 Bn |
| Mar 31, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.25 Bn |
| Sep 30, 2024 | 1.24 Bn |
| Jun 30, 2024 | 1.00 Bn |
| Mar 31, 2024 | 711.69 Mn |
| Dec 31, 2023 | 843.58 Mn |
| Sep 30, 2023 | 946.22 Mn |
| Jun 30, 2023 | 923.35 Mn |
| Mar 31, 2023 | 1.18 Bn |
| Dec 31, 2022 | 1.73 Bn |
| Sep 30, 2022 | 1.92 Bn |
| Jun 30, 2022 | 1.55 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.05 Bn |
| Sep 30, 2021 | 2.38 Bn |
API Access
Biocryst Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();